Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Understanding and overcoming resistance to PARP inhibitors in cancer therapy

20 Jul 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Integrated Circuits and Semiconductor Failure Analysis
Share to PARP inhibition in cancer therapy

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34285417
DOI: 10.1038/s41571-021-00532-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Understanding and overcoming resistance to PARP inhibitors in cancer therapyPMID 34285417Read ↗

PARP Inhibition in Cancer: An Update on Clinical DevelopmentSemantic proximity Read ↗

Preventing and Overcoming Resistance to PARP Inhibitors: A Focus on the Clinical LandscapeSemantic proximity Read ↗

PARP inhibitors in cancer therapy: Two modes of attack on the cancer cell widening the clinical applicationsSemantic proximity Read ↗

Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancerSemantic proximity Read ↗

New PARP targets for cancer therapySemantic proximity Read ↗

PARP inhibitors: pitfalls and promises.Semantic proximity Read ↗

Strategies for the prevention or reversal of PARP inhibitor resistance.Semantic proximity Read ↗

PARP inhibitors coming of ageSemantic proximity Read ↗

PARP inhibitors: the story is still unfolding.Semantic proximity Read ↗

PARP inhibitors in cancer therapy: an updateSemantic proximity Read ↗

Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP InhibitorsSemantic proximity Read ↗

PARP Inhibitors in Gynecologic Cancers: What Is the Next Big Development?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.